// App-Quantinova.ai

POS0656 (2021) : RELATIONSHIP BETWEEN CHANGES IN LIPID LEVELS AND IMPROVEMENT IN DISEASE ACTIVITY OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB TREATMENT: POOLED ANALYSIS OF DATA FROM TWO PHASE 3 STUDIES

Researchers

Presenter

  • C. Charles-Schoeman

Principal Investigators

  • J. T. Giles

  • N. Lane

  • E. Choy

  • H. Camp

  • Y. Song

  • I. McInnes

Medical Centers

  • University of California, Rheumatology, Los Angeles, United States of America

  • Columbia University Medical Center, Nephrology, New York, United States of America

  • University of California, Davis, Sacramento, United States of America

  • Cardiff University School of Medicine, Cardiff, United Kingdom

  • University of Glasgow, Glasgow, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • C reactive protein

  • Plasminogen Activator, Urokinase

Drug/Treatment

  • ABT-494

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved